515 filings
Page 3 of 26
SC 13G/A
wtf1c1h
4 Feb 20
GT Biopharma, Inc.
2:53pm
SC 13G/A
1k4ax9nz zdb
16 Jan 20
GT Biopharma, Inc.
4:30pm
EFFECT
lipmq
3 Oct 19
Notice of effectiveness
12:15am
CORRESP
4aq92j5tv80nuzvn
26 Sep 19
Correspondence with SEC
12:00am
8-K
k2gl21k 5z1ckli
24 Sep 19
GT Biopharma Announces the Sale of Its Fixed Dose Combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to Das Therapeutics
8:00am
UPLOAD
cb1c ugnsurz0
20 Sep 19
Letter from SEC
12:00am
8-K
05b0wdtpyud v3z
23 Aug 19
Entry into a Material Definitive Agreement
5:14pm
4
alo8v45f5lo 3b9v2
16 Aug 19
GT Biopharma / Tony Cataldo ownership change
4:57pm
4
cs0v5 8cw
16 Aug 19
GT Biopharma / Steven W Weldon ownership change
4:51pm
EFFECT
w6m0j
15 Jul 19
Notice of effectiveness
12:15am
CORRESP
l83izee6f87bepwg7
8 Jul 19
Correspondence with SEC
12:00am
UPLOAD
b6q jb0xngjtz
2 Jul 19
Letter from SEC
12:00am
8-K
1wbi1dyca
24 May 19
Entry into a Material Definitive Agreement
6:14am
8-K
mysa0h0kb2x5v44ne6
19 Apr 19
Unregistered Sales of Equity Securities
4:23pm